Sandell Scott D

-

Assets, Funds, Holdings

Home | Sign Up | Log In
⚲
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Sandell Scott D
✚
CIK #0001237289
EDGAR Form CIK 2011 - 2026
3 [0001237289]
4 [0001237289]
5 [0001237289]
Form 3/4/5 Subject 2011 - 2026
Cloudflare Inc
Sandell Scott D
Coursera Inc
Korro Bio Inc
Trevi Therapeutics Inc
SpyGlass Pharma Inc
NeueHealth Inc
BuzzFeed Inc
Baskett Forest
New Enterprise Associates 13 LP
NEA Partners 13 Limited Partnership
NEA 13 GP Ltd
NEA 15 GP LLC
NEA Partners 15 LP
Senti Biosciences Holdings Inc
Florence Anthony A Jr
Makhzoumi Mohamad
New Enterprise Associates 15 LP
NEA Partners 16 LP
Behbahani Ali
Chang Carmen
Walker Paul Edward
New Enterprise Associates 16 LP
Marker Therapeutics Inc
NEA 16 GP LLC
MBX Biosciences Inc
Kerins Patrick J
NEA Partners 14 LP
New Enterprise Associates 14 LP
NEA 14 GP Ltd
ZeroFox Holdings Inc
Sagimet Biosciences Inc
Synlogic Inc
Berkshire Grey Inc
Savara Inc
Mirum Pharmaceuticals Inc
Minerva Surgical Inc
Crescent Biopharma Inc
Sonsini Peter W
Oyster Point Pharma Inc
Arcellx Inc
Akouos Inc
IonQ Inc
PhaseBio Pharmaceuticals Inc
Aveo Pharmaceuticals Inc
Genocea Biosciences Inc
Robinhood Markets Inc
Enliven Therapeutics Inc
Bloom Energy Corp
Casper Sleep Inc
Ardelyx Inc
Metacrine Inc
Makower Joshua
NEA Partners 10 L P
CVRx Inc
Monte Rosa Therapeutics Inc
Desktop Metal Inc
Eargo Inc
OnKure Therapeutics Inc
Regulus Therapeutics Inc
Verona Pharma PLC
Sprout Social Inc
Mersana Therapeutics Inc
Inozyme Pharma Inc
Annexon Inc
Nkarta Inc
Surface Oncology Inc
Senseonics Holdings Inc
New Enterprise Associates 10 L P
Ra Pharmaceuticals Inc
Champions Oncology Inc
Mott David M
Black Diamond Therapeutics Inc
Adaptimmune Therapeutics PLC
NEA 12 GP LLC
Kineta Inc/DE
Barris Peter J
NEA Partners 12 Limited Partnership
New Enterprise Associates 12 Limited Partnership
Galera Therapeutics Inc
Nightstar Therapeutics PLC
Tesaro Inc
Tempest Therapeutics Inc
Viswanathan Ravi
Barrett M James
Elastic NV
Liquidia Technologies Inc
Mulesoft Inc
Tracon Pharmaceuticals Inc
Cascadian Therapeutics Inc
Tintri Inc
Oruka Therapeutics Inc
Appian Corp
Strongbridge Biopharma PLC
X4 Pharmaceuticals Inc
Carecom Inc
Rhythm Pharmaceuticals Inc
Zosano Pharma Corp
Achaogen Inc
Sorrento Tech Inc
Kolluri Krishna Kittu
Interleukin Genetics Inc
Opower Inc
TriVascular Technologies Inc
Epizyme Inc
Supernus Pharmaceuticals Inc
Avalo Therapeutics Inc
Vitae Pharmaceuticals Inc
Hyperion Therapeutics Inc
Drant Ryan D
Box Inc
Boingo Wireless Inc
Trevena Inc
Tableau Software Inc
Cvent Inc
Dermira Inc
Viracta Therapeutics Inc
Loxo Oncology Inc
Fusion-IO Inc
Aerohive Networks Inc
Workday Inc
Channeladvisor Corp
GYRE Therapeutics Inc
Audience Inc
XOOM Corp
Groupon Inc
Omthera Pharmaceuticals Inc
Clovis Oncology Inc
New Enterprise Associates 11 LP
NEA 11 GP LLC
NEA Partners 11 LP
Millennial Media Inc
Perry Mark W
Newhall Charles W III
Kramlich C Richard
InnerWorkings Inc
Amicus Therapeutics Inc
Echo Global Logistics Inc
Inhibitex Inc
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Korro Bio Inc KRRO
Common Stock
2026-03-10 Buy 207,100 $11.11 2,300,881
Korro Bio Inc KRRO
Pre-Funded Warrants · derivative
2026-03-10 Buy 242,945 $11.11 2,699,119
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Conversion 1,370,168
SpyGlass Pharma Inc SGP
Series B Preferred Stock · derivative
2026-02-09 Conversion 1,619,240
SpyGlass Pharma Inc SGP
Series A Preferred Stock · derivative
2026-02-09 Conversion 954,990
SpyGlass Pharma Inc SGP
Series D Preferred Stock · derivative
2026-02-09 Conversion 737,962
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Buy 937,500 $16.00 15,000,000
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Conversion 1,619,240
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Conversion 402,273
SpyGlass Pharma Inc SGP
Series C-2 Preferred Stock · derivative
2026-02-09 Conversion 1,370,168
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Conversion 737,962
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Conversion 1,370,168
SpyGlass Pharma Inc SGP
Series C-1 Preferred Stock · derivative
2026-02-09 Conversion 1,370,168
SpyGlass Pharma Inc SGP
Series B Preferred Stock · derivative
2026-02-09 Conversion 402,273
SpyGlass Pharma Inc SGP
Common Stock
2026-02-09 Conversion 954,990
NeueHealth Inc NEUE
Common Stock
2025-10-02 Tax withheld 276 $6.75 1,863
NeueHealth Inc NEUE
Common Stock
2025-10-02 Option exercise 124,085 $0.01 1,241
NeueHealth Inc NEUE
Common Stock
2025-10-02 Option exercise 372,255 $0.01 3,723
NeueHealth Inc NEUE
Series A Convertible Perpetual Preferred Stock · derivative
2025-10-02 Disposed to issuer 75,000
NeueHealth Inc NEUE
Warrant (Right to Buy) · derivative
2025-10-02 Option exercise 372,255 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com